Healthcare

in committee · New Jersey · General Assembly Feb 19, 2026

A 4314: Addresses long-term effects of COVID-19.

New Jersey's Assembly Bill A4314 establishes free post-COVID-19 health clinics for individuals previously diagnosed with the virus, providing physical and mental health evaluations, therapy, and related services at no cost. It mandates the state health department to create public awareness campaigns about long-term health effects, distribute educational materials in healthcare facilities, and train medical professionals on recognizing and addressing these effects. A new task force will specifically study how long-term health impacts disproportionately affect racial and ethnic minorities in the state. The bill expires one year after the end of New Jersey's official public health emergency for COVID-19.

Topics ✓ HealthcareSupports HealthcareEstablishes free post-COVID clinics providing physical/mental health services at no cost, expands access, and mandates provider training on long-term effects.95% confidence

Sub-Topics Mental Health Public Health

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 3093: Requires hospitals to provide breast cancer patients with information concerning reconstructive surgery; prohibits certain provisions in managed care plan contracts.

This New Jersey bill requires hospitals providing breast cancer surgical treatments (like mastectomy or lumpectomy) to give patients written notice at diagnosis - before surgery consent - about their rights to consult with any board-certified plastic surgeon (regardless of hospital or insurance network) and coverage for reconstructive surgery under state/federal law. It also prohibits health insurance contracts from blocking doctors from recommending plastic surgeons outside their network or denying reconstructive surgery coverage based solely on a surgeon’s network status. The policy applies specifically to patients undergoing treatment for breast cancer, breast cancer genes, or other breast abnormalities. Hospitals must provide this notice upon diagnosis, ensuring patients understand their options for reconstruction and coverage.

Topics ✓ HealthcareSupports HealthcareRequires hospitals to inform breast cancer patients of reconstructive surgery options and prohibits insurance restrictions, expanding patient access to care.95% confidence

Sub-Topics Hospitals Insurance

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 441: Establishes the "New Jersey Health Care and Privacy Protection Act"; bars disclosure of certain geolocation data.

This bill, the "New Jersey Health Care and Privacy Protection Act," prohibits businesses from disclosing precise geolocation data (like GPS coordinates within 1,750 feet) of individuals near reproductive health care facilities. It directly affects businesses that collect location data (e.g., apps, services) and patients seeking reproductive health care, including abortion, contraception, and pregnancy testing services. The key provision bans the sharing of such location data when individuals are near these facilities, while excluding public records or communication content. The law aims to protect patient privacy by preventing location tracking from being used to identify or target people accessing these services.

Topics ✓ HealthcareSupports HealthcareProtects patient privacy for reproductive health care by prohibiting geolocation data disclosure near facilities, aligning with 'protects patient rights' in healthcare services.90% confidence ✓ TechnologySupports TechnologyProhibits businesses from disclosing precise geolocation data near reproductive health facilities, strengthening data privacy protections for users.95% confidence

Sub-Topics Women's Health

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 2281: Requires Medicaid coverage for fertility preservation services in cases of iatrogenic infertility caused by medically necessary treatments.

This bill requires New Jersey Medicaid to cover fertility preservation services (like egg or sperm freezing) for individuals who develop infertility as a direct result of medically necessary treatments, such as cancer therapy. It directly affects Medicaid beneficiaries facing treatment-induced infertility who would otherwise pay out-of-pocket for these services. The key provision amends Medicaid coverage to include these services under "comprehensive medical care" when recommended by a physician prior to treatments known to cause infertility. The policy change ensures coverage for fertility preservation as part of standard medical care, without adding new administrative burdens to existing Medicaid services.

Topics ✓ HealthcareSupports HealthcareBill mandates Medicaid coverage for fertility preservation services, expanding insurance coverage and improving patient access for treatment-induced infertility without out-of-pocket costs.95% confidence

Sub-Topics Medicaid

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 538: "Pharmaceutical Representative Licensing Act."

This bill (A 538, "Pharmaceutical Representative Licensing Act") requires all individuals marketing pharmaceuticals to healthcare practitioners in New Jersey to obtain a state license. It directly affects pharmaceutical sales representatives, who must meet education, ethics, and background requirements, complete biennial continuing education (including opioid safety training), and report all interactions with doctors - including promoted drugs, samples given, and gifts provided. The State Board of Medical Examiners will oversee licensing, enforce standards (like banning deceptive marketing or false medical credentials), and may suspend licenses for violations. The bill aims to increase transparency and professionalism in pharmaceutical sales interactions.

Topics ✓ HealthcareSupports HealthcareRegulates pharmaceutical marketing with ethics training, transparency, and opioid safety requirements to protect patient safety and promote ethical healthcare interactions.85% confidence

Sub-Topics Substance Abuse Tags Licensing

Track

in committee · New Jersey · Senate May 18, 2026

S 3502: Requires health insurance and Medicaid coverage for treatment of stuttering.*

S 3502 requires all health insurance plans and Medicaid in New Jersey to cover stuttering treatment, including both habilitative (helping learn or maintain speech skills) and rehabilitative (restoring lost speech skills) speech therapy. It mandates coverage for in-person and telehealth services without cost-sharing like deductibles, copays, or annual limits, and eliminates prior authorization requirements. This directly affects all New Jersey residents with health insurance or Medicaid who need speech therapy for stuttering. The bill applies to all relevant insurance contracts issued in the state, ensuring consistent coverage for medically necessary stuttering treatment.

Topics ✓ HealthcareSupports HealthcareRequires insurance/Medicaid coverage for stuttering treatment, eliminating cost-sharing and prior authorization, expanding access to speech therapy services.95% confidence

Sub-Topics Insurance Medicaid Telehealth

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 1155: Establishes State Parkinson's disease registry.

New Jersey's Bill A1155 establishes a statewide Parkinson's disease registry to track the incidence and prevalence of Parkinson's disease and related conditions (Parkinsonisms) across the state. Health care providers must report diagnosed cases to the registry, including diagnostic details, treatment, and survival data, while allowing patients to opt out in writing. The registry collects only necessary health information, removes personal identifiers through coding, and strictly protects confidentiality - preventing disclosure in legal proceedings or for unauthorized uses. This data will support research, public health planning, and potentially improve care for those affected, with all reporting requirements applying to cases diagnosed both before and after the bill's effective date.

Topics ✓ HealthcareSupports HealthcareEstablishes public health registry for Parkinson's disease, tracking incidence/prevalence to improve disease data collection and inform healthcare strategies, aligning with public health program support.95% confidence

Sub-Topics Public Health

Track

in committee · New Jersey · General Assembly Jan 13, 2026

AR 16: Urges Congress to compel Department of Health and Human Services to fulfill its obligations pursuant to the National Childhood Vaccine Injury Act of 1986.

AR 16 is a New Jersey Assembly resolution urging Congress to require the U.S. Department of Health and Human Services (HHS) to comply with the National Childhood Vaccine Injury Act of 1986 (NCVIA). Specifically, it calls for HHS Secretary to submit the legally mandated biennial reports detailing actions taken to improve vaccine safety, which HHS has not done since 1989. The resolution does not create new requirements but seeks to compel HHS to fulfill existing obligations under the NCVIA. It directly affects HHS and Congress, as it requests congressional action to enforce the law. This is a procedural resolution, not a policy change.

Topics ✓ HealthcareSupports HealthcareUrges HHS compliance with vaccine safety reporting under NCVIA, protecting public health and patient safety through enforcement of existing healthcare obligations.95% confidence

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 2718: Requires continued coverage of prescription drugs for certain medical conditions.

This bill requires health insurers in New Jersey to maintain coverage for prescription drugs for individuals with complex/chronic medical conditions or rare diseases during any appeal stage if coverage was previously denied based on medical necessity. It prevents insurers from imposing new cost increases, coverage limits, or moving drugs to higher-cost tiers while an appeal is pending. Insurers may only deny coverage during an appeal if the prescribing doctor stops recommending the drug, the FDA issues a safety warning, or the drug manufacturer discontinues production. The law applies to all group and individual health insurance plans sold in New Jersey that cover prescription drugs.

Topics ✓ HealthcareSupports HealthcareMandates insurers maintain coverage during appeals for chronic/rare disease drugs, prevents cost increases, and protects patient access to necessary medications.95% confidence

Sub-Topics Insurance

Track

in committee · New Jersey · General Assembly Jan 13, 2026

A 3179: Provides civil immunity to licensed health care professionals who provide care at health care facilities for no compensation.

This bill (A 3179) grants civil immunity to licensed health care professionals who provide unpaid care at licensed health care facilities or nonprofit clinics, protecting them from lawsuits for personal injury resulting from that care. It applies to professionals like doctors, nurses, dentists, and therapists who do not bill for or expect payment for their services. The immunity does not cover cases of gross negligence or willful misconduct, as proven by clear evidence. Before providing care, professionals must inform patients about this immunity, and the law takes effect 60 days after enactment.

Topics ✓ HealthcareSupports HealthcareProtects volunteers from lawsuits, encouraging unpaid care access at clinics and supporting healthcare delivery.85% confidence

Track